AU2013901842A0 - Targeted delivery of drugs to the myometrium - Google Patents

Targeted delivery of drugs to the myometrium

Info

Publication number
AU2013901842A0
AU2013901842A0 AU2013901842A AU2013901842A AU2013901842A0 AU 2013901842 A0 AU2013901842 A0 AU 2013901842A0 AU 2013901842 A AU2013901842 A AU 2013901842A AU 2013901842 A AU2013901842 A AU 2013901842A AU 2013901842 A0 AU2013901842 A0 AU 2013901842A0
Authority
AU
Australia
Prior art keywords
myometrium
drugs
targeted delivery
targeted
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013901842A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle Innovation Ltd
Original Assignee
Newcastle Innovation Ltd
Filing date
Publication date
Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd
Publication of AU2013901842A0 publication Critical patent/AU2013901842A0/en
Priority to PCT/AU2014/050049 priority Critical patent/WO2014186843A1/en
Priority to AU2014271207A priority patent/AU2014271207B2/en
Priority to US14/892,927 priority patent/US10350167B2/en
Priority to EP14800670.3A priority patent/EP2999461B1/en
Priority to US16/435,061 priority patent/US10952964B2/en
Abandoned legal-status Critical Current

Links

AU2013901842A 2013-05-23 2013-05-23 Targeted delivery of drugs to the myometrium Abandoned AU2013901842A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/AU2014/050049 WO2014186843A1 (en) 2013-05-23 2014-05-23 Targeted delivery of drugs to the myometrium
AU2014271207A AU2014271207B2 (en) 2013-05-23 2014-05-23 Targeted delivery of drugs to the myometrium
US14/892,927 US10350167B2 (en) 2013-05-23 2014-05-23 Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies
EP14800670.3A EP2999461B1 (en) 2013-05-23 2014-05-23 Targeted delivery of drugs to the myometrium
US16/435,061 US10952964B2 (en) 2013-05-23 2019-06-07 Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

Publications (1)

Publication Number Publication Date
AU2013901842A0 true AU2013901842A0 (en) 2013-06-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP4005604B8 (en) Delivery of drugs
EP3019081A4 (en) Acoustic based drug delivery monitor
EP3047666A4 (en) Delivery of targeted media content
HRP20180684T1 (en) Drug combination
EP3082817A4 (en) Compositions for drug administration
ZA201507576B (en) Pharmaceutical combination drug
AU2014271207A1 (en) Targeted delivery of drugs to the myometrium
EP2999461A4 (en) Targeted delivery of drugs to the myometrium
AP2015008208A0 (en) Pharmaceutical administration forms comprising
HK1223833A1 (en) Pharmaceutical dosage forms
EP2898912A4 (en) Drug administration instrument
EP3046556A4 (en) Combination drug therapy
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
HK1213638A1 (en) Immune-potentiating drug nanocarriers
EP3006033A4 (en) Anticancer drug
GB201319437D0 (en) Delivery of drugs
EP3072516A4 (en) Antidepressant combination drug
AU2013901842A0 (en) Targeted delivery of drugs to the myometrium
IL244316A0 (en) Novel drug formulation
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
GB201319595D0 (en) Combination of Analgesic drugs
GB201316468D0 (en) Combination of analgesic drugs
PL2968201T3 (en) Enhanced drug delivery from adhesives
AU2013901119A0 (en) Nanoparticles for drug delivery
AU2013904872A0 (en) Nanocarrier